KR101770468B1 - Diet food manufacturing methods using natural mixture - Google Patents
Diet food manufacturing methods using natural mixture Download PDFInfo
- Publication number
- KR101770468B1 KR101770468B1 KR1020150096723A KR20150096723A KR101770468B1 KR 101770468 B1 KR101770468 B1 KR 101770468B1 KR 1020150096723 A KR1020150096723 A KR 1020150096723A KR 20150096723 A KR20150096723 A KR 20150096723A KR 101770468 B1 KR101770468 B1 KR 101770468B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- fat
- mixture
- hours
- diet
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 116
- 235000005911 diet Nutrition 0.000 title abstract description 61
- 230000037213 diet Effects 0.000 title abstract description 55
- 235000013305 food Nutrition 0.000 title abstract description 42
- 238000004519 manufacturing process Methods 0.000 title abstract description 22
- 241000196324 Embryophyta Species 0.000 claims abstract description 68
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 49
- 235000009566 rice Nutrition 0.000 claims abstract description 49
- 240000007594 Oryza sativa Species 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 43
- 239000000843 powder Substances 0.000 claims abstract description 41
- 239000000463 material Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 28
- 241000383638 Allium nigrum Species 0.000 claims abstract description 26
- 244000269722 Thea sinensis Species 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 23
- 235000009569 green tea Nutrition 0.000 claims abstract description 23
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000013336 milk Nutrition 0.000 claims abstract description 17
- 239000008267 milk Substances 0.000 claims abstract description 17
- 210000004080 milk Anatomy 0.000 claims abstract description 17
- 239000012141 concentrate Substances 0.000 claims abstract description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000013312 flour Nutrition 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 239000004310 lactic acid Substances 0.000 claims abstract description 7
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 7
- 238000012545 processing Methods 0.000 claims abstract description 6
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 238000005406 washing Methods 0.000 claims abstract description 4
- 238000003809 water extraction Methods 0.000 claims description 10
- 241001105098 Angelica keiskei Species 0.000 claims 1
- 230000004580 weight loss Effects 0.000 abstract description 15
- 244000061520 Angelica archangelica Species 0.000 abstract description 11
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 241000371652 Curvularia clavata Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 91
- 235000009200 high fat diet Nutrition 0.000 description 41
- 241000700159 Rattus Species 0.000 description 26
- 208000008589 Obesity Diseases 0.000 description 25
- 235000020824 obesity Nutrition 0.000 description 25
- 210000001789 adipocyte Anatomy 0.000 description 24
- 239000000047 product Substances 0.000 description 23
- 238000002360 preparation method Methods 0.000 description 21
- 201000010063 epididymitis Diseases 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 230000037396 body weight Effects 0.000 description 14
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 13
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 238000000605 extraction Methods 0.000 description 10
- 235000019786 weight gain Nutrition 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 235000008504 concentrate Nutrition 0.000 description 9
- 239000008103 glucose Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 230000004584 weight gain Effects 0.000 description 9
- 240000001810 Angelica gigas Species 0.000 description 8
- 235000018865 Angelica gigas Nutrition 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 8
- 238000010171 animal model Methods 0.000 description 8
- 230000003579 anti-obesity Effects 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 235000006533 astragalus Nutrition 0.000 description 7
- 230000000378 dietary effect Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 210000001596 intra-abdominal fat Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 6
- 235000018823 dietary intake Nutrition 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 235000013311 vegetables Nutrition 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 238000009530 blood pressure measurement Methods 0.000 description 5
- 235000021329 brown rice Nutrition 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000003494 hepatocyte Anatomy 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229940103115 simvastatin 20 mg Drugs 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000010903 husk Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000240 steatosis hepatitis Toxicity 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000011593 sulfur Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- VPFUWHKTPYPNGT-UHFFFAOYSA-N 3-(3,4-dihydroxyphenyl)-1-(5-hydroxy-2,2-dimethylchromen-6-yl)propan-1-one Chemical compound OC1=C2C=CC(C)(C)OC2=CC=C1C(=O)CCC1=CC=C(O)C(O)=C1 VPFUWHKTPYPNGT-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 206010014733 Endometrial cancer Diseases 0.000 description 2
- 206010014759 Endometrial neoplasm Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 244000111489 Gardenia augusta Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229960003284 iron Drugs 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000005228 liver tissue Anatomy 0.000 description 2
- 235000020845 low-calorie diet Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000007863 steatosis Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical class C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- 235000003276 Apios tuberosa Nutrition 0.000 description 1
- 229930091051 Arenine Natural products 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 235000005320 Coleus barbatus Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- 108700032819 Croton tiglium crotin II Proteins 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000372132 Hydrometridae Species 0.000 description 1
- 206010020524 Hydronephrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000030999 Monascus pilosus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000131459 Plectranthus barbatus Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 241000047339 Salicornia brachystachya Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 244000170226 Voandzeia subterranea Species 0.000 description 1
- 235000013030 Voandzeia subterranea Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- 108010083364 chungkookjang Proteins 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- -1 fatty acid compound Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 201000010175 gallbladder cancer Diseases 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000007924 ground bean Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 239000008361 herbal raw material Substances 0.000 description 1
- 238000013224 high-fat diet-induced obese mouse Methods 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a method for producing a diet food using a natural mixture, and more particularly, to a method for manufacturing a diet food using a natural mixture, which comprises mixing natural materials good for a human body such as trifoliate, black garlic, and rice bran to benefit the body and has a synergistic effect on weight loss, Quot; a method for producing a diet food using a natural mixture "
A method for producing a diet food using a natural mixture according to an embodiment of the present invention includes the following steps.
(a) preparing a plant mixture of nine different materials by washing with water nine kinds of materials such as a tripe, black garlic, green tea, malt, angelica,
(b) mixing 5 to 7 liters of water with 1 kg of the weight of the plant mixture of the above-prepared nine materials, and then heating the mixture at 110 to 120 DEG C for 3 to 5 hours to extract the extract;
(c) heating the extracted plant mixture extract at a temperature of from 60 to 80 ° C for 5 to 7 hours to concentrate the concentrate to a concentration of 4 to 5 brix,
(d) The plant mixture of the nine materials prepared in the step (a) is steamed for 50 to 70 minutes with makgeolli, and the plant mixture is prepared by the method. Drying for 30 hours to form a powder,
(e) Mix the milk with the rice flour and mix it with hot water for 50 ~ 70 minutes. Add the lactic acid bacteria to the cooked rice flour at 35 ~ 45 ℃ and ferment it for 70 ~ 74 hours. Drying it for 20 to 30 hours and processing it into a fermented rice bran powder,
(c) is mixed at a ratio of 1: 0.2-0.4: 0.1-0.3, and the granulated product is processed into granules. The powder of step (d) .
Description
The present invention relates to a method for producing a diet food using a natural mixture, and more particularly, to a method for manufacturing a diet food using a natural mixture, which comprises mixing natural materials good for a human body such as trifoliate, black garlic, and rice bran to benefit the body and has a synergistic effect on weight loss, Quot; a method for producing a diet food using a natural mixture "
As we entered the modern age, the nutritional status improved and people's physique improved. However, overeating of nutrition and the lack of exercise due to changes in the living environment also caused a sudden increase in the incidence of obesity.
Obesity is clinically involved in the development of various diseases or exacerbating the disease. Obesity-related diseases include hypertension, camellias, diabetes, fatty liver and gallstones, and gout. In particular, endometrial cancer, gallbladder cancer, cervical cancer, ovarian cancer, and breast cancer are more common in women, and the incidence of obesity and mortality in endometrial cancer is the most remarkable in comparison with other cancer diseases.
In addition, obesity is reported to be 1.3 times higher than normal weight in mortality.
Therefore, it is necessary to prevent obesity in advance, and in the case of obesity, it is important to lose weight quickly to make normal body weight so that smooth body metabolism can be achieved.
Many dieting methods have been introduced to date because of the high interest and effort of obese people to pay attention to weight loss. For example, apple diet, , Difference in cost ratio, moxibustion, and toning system.
Although these methods have some weight loss effect, the effect is insignificant, and it is easy to cause considerable strain on the body due to nutritional imbalance.
This is because these methods are usually not excessive weight loss, but nutritional or scientific approaches. In other words, they can not provide essential nutrients to the body properly, and because they do not have a scientific basis for weight loss, diet is a diet method. Therefore, as the food quantity decreases, the bowel function becomes poor and the supply of vitamins and minerals becomes inadequate And the metabolism is not done properly.
More importantly, although weight loss should be achieved by a decrease in body fat, these diet methods are more likely to cause discomfort to the body as the amount of fat, such as muscle, is reduced rather than body fat.
Another method used in the diet method is drug therapy using an appetite suppressant such as an amphetamine derivative. The pharmacotherapy does not sustain the appetite suppressing ability and is only a transient action, and the blood pressure increase, headache, insomnia, irritability, tense, dizziness, There is a problem that side effects such as hallucinations are caused. Although diuretics can be used to lose weight, this method can lead to addiction to the kidneys and side effects such as vomiting and heart attack.
Therefore, many diet methods should be carefully reviewed and performed, but in most cases it is not the case, which often causes problems.
The preferred dietary food should have a proper ratio of protein and carbohydrate, a proper proportion of animal protein and vegetable protein, a sufficient amount of dietary fiber, and a rich vitamin and mineral .
Conventional known patents and documents related to weight loss are as follows.
1) JP-A 6-343421 (Dec. 20, 1994) In a high-quality food having an ability to prevent obesity, a high-quality food containing high-quality main ingredient and Kimmeasan, a high-quality main ingredient and an acidic precipitate of Kim Nemil- .
2) Japanese Laid-Open Patent Publication No. 6-133731 (Apr. 5, 1994) describes a food containing a root, root powder, water or alcohol extract of Coleus forskohlii.
3) Japanese Unexamined Patent Publication (Kokai) No. 5-284937 (Nov. 1, 1993) Inhibitory activity of digestive enzymes obtained from seaweeds and dietary foods containing them, the extracts such as brown algae, green algae and red algae inhibit high alpha-amylase activity But also has a lipase activity inhibiting action.
4) Japanese Laid-Open Patent Publication No. 5-84045 (Apr. 4, 1993) describes a method of preparing freeze-dried rice by adding 0.2-4.5 wt% of a fatty acid compound to uncooked rice and lyophilization.
Also, non-patent references refer to low-calorie diets, extreme low-calorie diets, and the like in the dietary therapy of obesity (Korean Journal of Medicine, 37, No. 9, 1994, 1023-1027).
In addition, products on the market include dietary fiber products, milk protein products, and granular products using Chinese medicine.
However, the above-described techniques have failed to obtain an effective diet effect by using an artificial drug or the like in order to obtain an animal product or a short-term effect.
Therefore, there has been a desperate need to solve the problems that can not be solved by the above-described techniques and to develop long-term, continuous and natural diet foods.
The present invention has been made in order to solve the problems of the prior art and to provide an effective weight loss effect and to maintain or improve the function of the body, and it is possible to mix natural materials suitable for human body such as trifoliate, black garlic, , Which has a synergistic effect on weight loss and body fat reduction, and maintains or improves body function.
In order to accomplish the above object, a method for producing a diet food using a natural mixture according to an embodiment of the present invention includes the following steps.
(a) preparing a plant mixture of nine different materials by washing with water nine kinds of materials such as a tripe, black garlic, green tea, malt, angelica,
(b) mixing 5 to 7 liters of water with respect to 1 kg of the plant mixture of the above-prepared nine materials, followed by hot water extraction at 110 to 120 DEG C for 3 to 5 hours;
(c) heating the extracted plant mixture extract at a temperature of from 60 to 80 ° C for 5 to 7 hours to concentrate the concentrate to a concentration of 4 to 5 brix,
(d) The plant mixture of the nine materials prepared in the step (a) is steamed for 50 to 70 minutes with makgeolli, and the plant mixture is prepared by the method. Drying for 30 hours to form a powder,
(e) Mix the milk with the rice flour and mix it with hot water for 50 ~ 70 minutes. Add the lactic acid bacteria to the cooked rice flour at 35 ~ 45 ℃ and ferment it for 70 ~ 74 hours. Drying it for 20 to 30 hours and processing it into a fermented rice bran powder,
(c) is mixed at a ratio of 1: 0.2-0.4: 0.1-0.3, and the granulated product is processed into granules. The powder of step (d) .
According to the experiment result report of domestic universities, the food obtained according to the method of manufacturing diet food using the natural mixture proposed in the present invention has an advantage that the body weight is significantly decreased as compared with the control group.
In addition, weight, weight gain, dietary intake, and dietary efficiency have a weight loss effect compared to the drug control.
1 is a flowchart of a method of manufacturing a diet food using a natural mixture according to an embodiment of the present invention.
2 is a photograph showing a scoring according to a ballooning injury.
3 is a graph showing the effect of the fat control according to the weight conversion of the experimental rat.
FIG. 4 is a graph showing the effect of Pat Control (FC) according to the blood glucose measurement result of an experimental rat.
5 is a graph showing the effect of Pat Control (FC) according to the blood pressure measurement result of an experimental rat.
Fig. 6 is a photograph showing a state of being opened after the end of the experiment.
FIG. 7 is a graph showing the effect of fat control according to weight comparison in a liver of an experimental rat. FIG.
FIG. 8 is a graph showing the effect of the fat control according to the relative weight comparison between the liver of an experimental rat.
9 is a graph showing the effect of fat control according to the comparison of the weight of the spleen of the experimental rats.
10 is a graph showing the effect of the fat control according to the relative weight comparison of the spleen of an experimental rat.
11 is a graph showing the effect of fat control according to weight comparison of peritoneal fat in an experimental rat.
FIG. 12 is a graph showing the effect of the fat control according to the comparison of the relative weights of the peritoneal fat in the experimental rats.
FIG. 13 is a graph showing the effect of fat control according to weight comparison of epididymal fat of an experimental rat.
14 is a graph showing the effect of the fat control according to the comparison of the relative weights of the epididymal fat of the experimental rats.
FIG. 15 is a graph showing the effect of fat control according to weight comparison of peripheral fat of an experimental rat. FIG.
16 is a graph showing the effect of fat control according to the comparison of the relative weights of the fat around the kidneys of the experimental rats.
17 is a diagram showing the effect of fat control according to the result of fat accumulation.
18 is a photograph showing the effect of fat control according to the result of fat accumulation.
FIG. 19 is a graph showing the effect of the fat control according to the results of observing epididymal adipocytes. FIG.
FIG. 20 is a photograph showing the effect of Fat Control according to observation results of epididymal adipocytes. FIG.
21 is a diagram showing the effect of fat control according to the results of observation of peritoneal fat adipocytes.
22 is a photograph showing the effect of Fat Control according to the results of observation of peritoneal adipocytes.
FIG. 23 is a graph showing the effect of fat control according to the observation of the adipocyte around the kidney. FIG.
24 is a photograph showing the effect of fat control according to the observation of the fat surrounding fat cells.
Hereinafter, a method for producing a diet food using a natural mixture according to an embodiment of the present invention will be described in detail.
In addition, a product manufactured according to the method for producing a diet food using a natural mixture according to an embodiment of the present invention corresponds to a fat control.
1 is a flowchart of a method of manufacturing a diet food using a natural mixture according to an embodiment of the present invention.
As shown in FIG. 1, a method for producing a diet food using a natural mixture according to an embodiment of the present invention comprises the steps of: preparing a concentrated liquid by making hot water extraction of the active ingredient of nine kinds of materials, Preparing nine kinds of materials separately as powders, and preparing a raw rice bran powder, mixing the concentrate, the powder and the raw rice bran powder, and processing the mixture into granules.
The method of manufacturing a diet food using the natural mixture according to the first embodiment of the present invention is as follows.
1. Plant mixture preparation step (SA100);
Prepare 9 kinds of materials such as tripe, black garlic, green tea, malt, angelica, urogum, hwanggi, crust, and mountain horses. At this time, the composition ratio is 10 to 20 wt%, 3 to 8 wt% of black garlic, 5 to 15 wt% of green tea, 5 to 15 wt% of malt, 5 to 15 wt% of angelica, 5 to 15 wt% By weight, 10 to 20% by weight, and 5 to 15% by weight, respectively.
However, the composition ratio of the nine materials may deviate from some categories depending on human constitution. Clean the nine pieces of material as described above two or three times in clean water and remove the water.
In the present invention, nine kinds of materials are selected as the plant mixture , namely, watery plants, watery plants, watery plants ,
In the present invention, the plant mixture (nine kinds of materials such as three kinds of vegetables, black garlic, green tea, malt, Angelica gigas, It is also good for early onset of hypertension, hyperlipidemia, arteriosclerosis, heart failure, cardiac dysfunction, palpitations, arrhythmia, vascular neuropathy and so on. In addition, it was confirmed that application to hepatosplenomegaly and splenomegaly is effective. It is good to eat 9-15g a day with water, powder or salt.
2. Hydrothermal extraction step of plant mixture (SA210);
The plant mixture prepared in the plant mixture preparation step (SA100) was extracted by hot water extraction at 110-120 ° C, and 9 kinds of ingredients (three kinds of vegetables, black garlic, green tea, malt, Angelica gigas, ,
3. Plant mixture concentration step (SA220);
Concentrate the extract which is hot water extracted in the plant mixture hydrothermal extraction step (SA210), and heat it at 60 ~ 80 ℃ for 5 ~ 7 hours to concentrate it to 4 ~ 5brix concentrate.
4. Plant mixture powder step (SA230);
The plant mixture prepared in the plant mixture preparation step (SA100) is steamed for 50 to 70 minutes with makgeolli, and dried by processing at 60 to 80 ° C for 20 to 30 hours, and then processed into powder.
That is, the plant mixture was subjected to a steaming process using a makgeolli, placed on a breathable fiber, and then heated to a state in which the makgeolli was placed on an enclosure containing makgeolli. The mixture was steamed for 50 to 70 minutes, ), And then dried at 60 to 80 ° C for 20 to 30 hours and then processed into powder.
The reason why the plant mixture is made by makgeolli is that the good ingredients of makgeolli are penetrated into the material as much as possible while maximizing the efficacy of the ingredients and activating the blood circulation (blood sugar) Action). In addition, digestion and absorption are good when taken.
For reference, recent literature suggests that the effects of rice wine such as fatigue relief, skin regeneration and whitening effect, visual acuity improvement, liver function improvement, cholesterol lowering, blood flow improvement, cancer cell growth inhibition and cancer prevention.
In addition, the reason for drying the plant mixture legume with makgeolli is that it is firstly processed into powder, and secondly, the product is easily configured according to the use.
These dried materials are then processed into powders. In this case, the water content before and after drying becomes 10 to 15%.
5. Preparation step of rice bran (SA300);
First, prepare high-quality rice flour, mix the prepared rice flour with milk, heat it with hot water for 50 ~ 70 minutes, steamed rice flour is cooled to 35 ~ 45 ℃ and lactic acid bacteria are added. After fermentation for a time, it is dried at 65 ~ 75 ℃ for 20 ~ 30 hours and processed into powder.
At this time, in order to prepare the rice bran powder, prepare the rice bran powder, mix the prepared rice bran powder with milk, and boil it for 50 ~ 70 minutes with hot water.
Next, the rice flour is cooled to 35 ~ 45 ℃ and lactic acid bacteria are added and fermented for 70 ~ 74 hours.
Next, the fermented rice bran is dried at 65 to 75 ° C for 20 to 30 hours to be processed into a powder.
Through this process, it is possible to prepare a fermented rice powder and produce a nutritious diet food.
In particular, fermented rice bran powder is useful for the treatment of adult diseases, and the intestinal environment may change from weakly alkaline to weakly acidic to regenerate bodily tissues and regulate blood pressure and blood sugar. Also, the brown rice octacosanol ingredient improves physical strength, strengthens muscle endurance, and breaks down cholesterol to improve blood circulation. Rich lactic acid bacteria promote digestion and release toxins in the body. Pinyin in brown rice emits heavy metals and pesticides in the body. Brown rice rice bran is rich in vitamin E and has antioxidant activity.
For reference, rice bran is made from rice bran and rice husk in a home made from brown rice to white rice. Rice bran is a by-product in the process of rice cultivation, but it is rich in nutrients of rice and contains various nutrients such as vitamin A, vitamin B1 and B6, iron, and minerals.
It is effective to prevent cancer through anticancer effect because it contains beta-cysterol and pitic acid. It is used as a pack to cover the skin and smooth the surface of the skin. It is good for skin beauty. It is rich in dietary fiber, It is good for relief and cleanse the chest.
6. Product Completion Stage (SA400);
The mixture of the concentrate of the plant mixture concentration step (SA220), the powder of the plant mixture powder step (SA230) and the rice bran fermentation powder of the rice bran preparation step (SA300) are mixed and granulated, Complete with product.
The mixing ratio of the powder of the plant mixture powder step (SA230), the rice bran preparation temperature of the rice bran preparation step (SA300) and the concentrate of the plant mixture concentration step (SA220) is 1: 0.2-0.4: 0.1-0.3 weight ratio do.
In the present invention, the plant mixture powder of the plant mixture powder stage (SA230), the rice fermentation powder of the rice bran preparation stage (SA300), and the plant mixture concentrate of the plant mixture concentration stage (SA220) are referred to as a natural mixture.
The thus-mixed natural mixture is mixed with the concentrate of the plant mixture powder (SA230) in the fine powder state and the rice bran fermentation powder in the rice bran preparation step (SA300) in the appropriate liquid plant concentration step (SA220) The components become sticky and the powder agglomerates to form
Thus, through the above-described process, the product completed with the natural mixture becomes a food having a diet effect, which is convenient for the general people to eat. Since the plant mixture is prepared by mixing the plant mixture with the concentrate and the powder, As a result, the function of the diet was increased.
A method of manufacturing a diet food using a natural mixture according to a second embodiment of the present invention will be described below.
1. Plant mixture preparation step (SB100);
Prepare 9 kinds of materials such as tripe, black garlic, green tea, malt, angelica, urogum, hwanggi, crust, and mountain horses. At this time, the composition ratio is 10 to 20 wt%, 3 to 8 wt% of black garlic, 5 to 15 wt% of green tea, 5 to 15 wt% of malt, 5 to 15 wt% of angelica, 5 to 15 wt% By weight, 10 to 20% by weight, and 5 to 15% by weight, respectively.
However, the composition ratio of the nine materials may deviate from some categories depending on human constitution. Clean the nine pieces of material as described above two or three times in clean water and remove the water.
At this time, in the present invention, nine kinds of materials are selected as the plant mixture , such as three-layered, black garlic, green tea, malt, Angelica gigas,
2. Plant mixture hot water extraction step (SB200);
The plant mixture prepared in the plant mixture preparation step (SB100) was extracted by hot water extraction at 110-120 ° C, and nine kinds of ingredients (three kinds of vegetables, black garlic, green tea, malt, Angelica gigas, ,
3. Diet drink preparing step (SB300);
Prepare a proven diet drink that is on the market.
Here, diet drinks are basically drinks that lose weight when they drink. Among them, there are green tea drinks. Green tea has the effect of reducing digestion and eating flesh.
4. Product completion stage (SB400);
After mixing the extract of the plant mixture hydrothermal extraction step (SB200) and the diet drink of the diet drink preparation step (SB300), the beverage is processed into a liquid beverage so that it can be easily made into a product for the general public to eat.
At this time, the ratio of the extract solution: diet beverage weight in the plant mixture hot water extraction step (SB200) is 1: 5-10.
As a result, the diet product is completed using a natural mixture which is easy to drink and is expected to have a diet effect because the general public does not have any resistance to eating.
A method of manufacturing a diet food using a natural mixture according to a third embodiment of the present invention will now be described.
1. Plant mixture preparation step (SC100);
Prepare 9 kinds of materials such as tripe, black garlic, green tea, malt, angelica, urogum, hwanggi, crust, and mountain horses. At this time, the composition ratio is 10 to 20 wt%, 3 to 8 wt% of black garlic, 5 to 15 wt% of green tea, 5 to 15 wt% of malt, 5 to 15 wt% of angelica, 5 to 15 wt% By weight, 10 to 20% by weight, and 5 to 15% by weight, respectively.
However, the composition ratio of the nine materials may deviate from some categories depending on human constitution. Clean the nine pieces of material as described above two or three times in clean water and remove the water.
At this time, in the present invention, nine kinds of materials are selected as the plant mixture , such as three-layered, black garlic, green tea, malt, Angelica gigas,
2. Plant mixture hot water extraction step (SC200);
The plant mixture prepared in the plant mixture preparation stage (SC100) was extracted by hot water extraction at 110-120 ° C, and the nine kinds of materials (three kinds of vegetables, black garlic, green tea, malt, Angelica gigas, ,
3. Dutch coffee preparation step (SC300);
Prepare a good quality Dutch coffee that is sold on the market.
Here, Dutch coffee refers to coffee that has been used over a long period of time by using cold water or normal-temperature water instead of hot water. The name "Dutch coffee" is a Japanese name for Dutch coffee, and in English it is called "cold brew."
For the manufacturing method, put the ground coffee into the special equipment, and extract the coffee stock solution in cold water or at room temperature for 3 to 4 hours for short time, 8 to 12 hours for long time. Depending on the method of extraction, it is divided into a dropping method and a leaching method. Dripping is a way to make a drop of coffee from a container drop by drop, which is why it is called 'coffee tears'. The leaching method is a method in which the ground beans and water are added to the container and aged at room temperature for about 10 to 12 hours, and then the residue is filtered to remove the undiluted solution.
Because it is extracted over a long period of time, it is less bitter than ordinary coffee extracted in a short time with hot water, and it can feel a mild and soft flavor. The degree of grinding of bean, taste of water and extraction time are important. The extracted coffee liquid is stored in a sealed refrigerator. If it is matured for a day or two at a low temperature, the flavor will survive more. It is common to drink milk or syrup or water to dilute or drink with ice depending on the taste rather than just drinking the raw solution.
4. Product completion stage (SC400);
After mixing the extract of the plant mixture hydrothermal extraction step (SC200) with the Dutch coffee of the Dutch coffee preparing step (SC300), it is processed into a liquid beverage and finished as a product for the general public to eat easily.
At this time, the weight ratio of extract: Dutch coffee in the plant mixture hydrothermal extraction step (SC200) is 1: 8-12.
A method of manufacturing a diet food using the natural mixture according to the fourth embodiment of the present invention will now be described.
1. Plant mixture preparation step (SD100);
Prepare 9 kinds of materials such as tripe, black garlic, green tea, malt, angelica, urogum, hwanggi, crust, and mountain horses. At this time, the composition ratio is 10 to 20 wt%, 3 to 8 wt% of black garlic, 5 to 15 wt% of green tea, 5 to 15 wt% of malt, 5 to 15 wt% of angelica, 5 to 15 wt% By weight, 10 to 20% by weight, and 5 to 15% by weight, respectively.
However, the composition ratio of the nine materials may deviate from some categories depending on human constitution. Clean the nine pieces of material as described above two or three times in clean water and remove the water.
At this time, in the present invention, nine kinds of materials are selected as the plant mixture , such as three-layered, black garlic, green tea, malt, Angelica gigas,
2. Hydrothermal extraction step of plant mixture (SD200);
The plant mixture prepared in the plant mixture preparation step (SD100) was extracted by hot water extraction at 110-120 캜, and the nine kinds of ingredients (three kinds of vegetables, black garlic, green tea, malt, Angelica gigas, ,
3. milk preparation step (SD300);
We prepare good quality milk sold on the market.
Milk is composed of water, fat, protein, lactose, major components of minerals and trace elements such as vitamins and enzymes. As such, milk contains not only all kinds of nutrients required for human body but also high absorption / utilization ratio, which is known as the most complete food as a single food.
Milk fat, lactose and protein as nutrients are the source of heat and energy. Especially milk proteins contain essential amino acids in a balanced manner, and the amount is higher than that of other foods.
Lactose is a carbohydrate contained only in the milk of a mammal. It plays an important role in assisting the absorption of calcium, phosphorus, iron and vitamin D, which is important for the development of the child, and promotes intestinal osmotic pressure to promote interlocking of the intestinal tract. .
Milk is also excellent as an inorganic source required by the human body. In particular, milk contains a ratio of calcium to phosphorus, a ratio of calcium to potassium, and a ratio of magnesium to sodium.
In addition, milk contains various vitamins, so it can be a source of vitamins, but vitamin D content is very small, so it is desirable to strengthen vitamin D in commercial milk.
4. Product completion stage (SD400);
The mixture of the extract of the plant mixture hydrothermal extraction step (SD200) and the milk of the milk preparation step (SD300) is mixed at a weight ratio of 1: 3 ~ 5, the lactic acid bacteria are injected and fermented to prepare yogurt.
This finished yogurt is a food that is easy to eat and has an effect on the diet.
Hereinafter, the product manufactured in the method for producing a diet food using the natural mixture according to an embodiment of the present invention is tested for its efficacy according to the following research and experiment results.
The product manufactured by the method of producing a diet food using the natural mixture according to the first embodiment of the present invention is abbreviated to Fat Control in order to easily identify the product, The experimental result report was prepared.
<Experimental Results Report>
Effect of Mixed Extracts from Herbal Medicinal Herbs on High Fat Diet Induced Anti-Obesity in Mice
Title: Anti-obesity effect of herb extracts from high-fat diet
Test Number: I.M.D-A-15000-01
Approval number: WKU15-10
This test was carried out in accordance with the approved test plan, and the test procedure described in this report was carried out under the responsibility of the test taker. The report was based on the test baseline data obtained from the test run.
Institute for Metabolic Diseases, Wonkwang University
Ⅰ. Materials and methods
1. Experimental material
The herbal composition complex extracts used in this experiment were tested using Fat-control products produced from herbal life oriental herbs (applicants) based on 13 herbal ingredients. (For reference, the 13 kinds of herbal raw materials are nine kinds of herbal ingredients such as three kinds of herb, black garlic, green tea, malt, angelica, , And four dermis.)
2. Experimental animals
Three-week-old male ICR mice were purchased from Daejeon (Korea) and used for a week for purification period.
The average weight of ICR mice was 25.85 ± 0.11 g, which induced obesity through a high fat diet (central laboratory animal, Korea) and at the same time oral administration of natural extracts was administered once a day.
The experimental animals were kept in dark room at 12 ± 12 ℃, temperature of 23 ± 2 ℃ and humidity of 50 ~ 60%. This animal test was conducted in accordance with the Guide for Animal Experimentation of Wonkwang University and approved by the Wonkwang University Animal Experimental Ethics Committee (Approval No. WKU15-10). High-fat diets (Rodent Diet with 60% kcal fat) were purchased from Daejeon, Korea. The composition of the diets was as follows (Table 1).
Table 1. Composition of experimental diets
3. Military composition
(HFD, n = 6), high fat diets were fed a diet containing high fat diets, and diabetic rats were fed a high fat diet (N = 6) and Simvastatin 20 mg / kg (SIM, n = 6), respectively. The minimum number of statistical significance was used according to the principle of 3R. Normal and control groups were administered D.W. Each sample was orally administered once a day.
Table 2. Experimental design for 6-week animal study of anti-obesity effects by the Fat Control
[NC; Normal Diet control group, HFD; high fat diet control group, SIM; high fat diet + Simvastatin 20 mg / kg, FC; high fat diet + Fat Control]
4. Weight and Diet amount , Quantity of water Measure
The body weight was measured using a digital meter (IB-3100, Innotem, Yangju) at intervals of 1 week, at a fixed time (AM 10:00) AM, 10 o'clock). The Food Efficiency Ratio (FER) was calculated by dividing the weight gain during the experimental period by the dietary intake over the same period.
5. Fasting blood glucose, blood pressure measurement
The fasting blood glucose concentration of the experimental animals was measured 6 weeks after the start of the experiment. The blood was collected from the tail vein after fasting for 12 hours before measurement and measured using a glucose meter (Accu-CHEK® Active GC, Roche, Germany). Blood pressure was measured using a mouse tail blood pressure system (MK-2000STS, MUROMACHI KIKAI, Japan). After placing the piezoelectirc pulse sensor and occlusion cuff in the tail of the mouse, the pulse signal connected to the computer was observed to a reasonable degree. At this time, the systolic blood pressure was observed by operating the device, and the blood pressure was measured 7 times per sperm.
6. Long term weighing
The organs were harvested by weighing liver, spleen, epididymal fat, retroperitoneal fat and peri-renal fat immediately after blood sampling and then weighing the animals And the relative long-term weights were obtained. The relative weight (%) was calculated as (long-term / weight) × 100.
7. Histopathological inspection
Liver, epididymal fat, retroperitoneal fat, and peri-renal fat to confirm the accumulation of liver tissue and lipids in adipose tissue collected at the end of the study. After washing with physiological saline, water was removed with filter paper. A portion of the liver tissue was fixed in 10% neutral formalin for histological examination. Using a conventional method for histopathological examination, After the sections were cut to a thickness of 4 μm, slides were made and hematoxyline & Eosin (H & E) staining was performed. The NASH (nonalcoholic steatohepatitis) score was measured at 200x magnification using Carl Zeiss Microscopy Axio Imager M1 (ZEISS, Germany) Respectively.
NASH is a nonalcoholic fatty hepatitis characterized by the presence of three lesions, mainly giant hydronephrosis, hepatocyte injury, and mixed inflammation, distributed in three areas and central lobes. The NASH score was assessed by scanning the slides with H & E stain using an optical microscope and comparing the score of the degree of adiposity, balloon degeneration, and lobular inflammation to NASH score of 5 or higher and NASH score of 2 or less (Neuschwander et al. , 2010).
Standard of NASH scoring
1. Steatosis Grade: Low-to-medium-power evaluation of parenchymal involvement
[0: <5%, 1: 5 - 33%, 2:> 33% - 66%, 3:> 66%]
2. Lobular Inflammation: Lobular inflammation Overall assessment of all inflammatory foci
[0: No foci., 1: < 2 foci per 200X field, 2: 2-4 foci per 200X field,
3. Hepatocellular ballooning (0-2)
[0: None, 1: Few balloon cells, 2: Many cells / prominent ballooning]
2 is a photograph showing a scoring according to a ballooning injury.
8. Statistical processing
The results obtained in this experiment are expressed as mean ± SD (mean ± SD). Statistical significance of each test group was analyzed using the One-way Anova SPSS v.12 for statistical comparison between the control and experimental groups, and Duncan's post test (p <0.05) was statistically significant Respectively.
Ⅱ. Results and Discussion
1. Weight measurement results
The anti-obesity effect of chungkukjang was investigated by 7-week animal test.
Overall, in the sample-treated group, weight gain was reduced compared to the control group, HFD, whereas the drug-treated group did not show significant weight loss when compared to HFD. From 5th week, weight loss was significantly decreased in FC group compared to HFD group.
FIG. 3 is a graph showing the effect of the fat control according to the weight conversion of the experimental rat. (Effects of Fat Control on Body Weight in a ICR Mouse Obesity Model induced by a High Fat Diet)
Particularly, as shown in Fig. 3, although the general diet group (NC) and the high fat diets were diet Pat because they show a control for articles (FC) is about the same body weight change in a dose (Fat Control), it can be seen that the effect of the fat control (Control Fat) corresponds.
2. Dietary intake, weight gain and Dietary efficiency Measurement result
Weight gain, weight gain, dietary intake, and diet efficiency of 7-week animal studies were as follows (Table 3).
The average weight of the high - fat diet was 25.44 ~ 26.25g. However, the weight gain after 7 weeks increased by 33.5% in NC group, 46.6% in control group, 42.2% in control group, and 41.5% in FC group, respectively. These results suggest that weight loss is more effective than drug control in the case of dietary intake similar to that of the other groups except NC group. In the study by Lee (1) et al., The rate of increase was less in the HFD group than in the NC group, but the rate of weight gain per week in the sample-treated group was low.
Thus, referring to FIG. 3, the Pat control group (FC group) showing almost the same weight change as the normal group (NC) can obtain the most ideal effect as compared with the other control group.
Table 3. Effects of Fat Control on body weight gain and feed efficiency ratio of mice fed high fat supplemented diets for 7 weeks
Measurements
3. Results of blood glucose and blood pressure measurement
3.1. Blood glucose measurement result
The result of 5th blood glucose measurement is as follows (Fig. 4). The blood glucose level of the NC group was 94.67 ± 4.51 mg / dL, which was similar to that of the simvastatin-treated group (94.00 ± 4.51 mg / dL) and the FC group (111.00 ± 9.54 mg / dL) , Which was higher than that of the NC group and the SIM group, but lower than that of the HFD group (118.75 ± 23.16 mg / dL).
FIG. 4 is a graph showing the effect of Pat Control (FC) on blood glucose measurement in an experimental rat.
3.2. Blood pressure measurement result
The results of the 5th blood pressure measurement are as follows (Fig. 5). The blood pressure of the NC group was 121.80 ± 14.82 mmHg, which was 117.83 ± 9.54 mmHg in the SIM group and 117 ± 8.02 mmHg in the FC group, which was significantly lower than the 150.00 ± 16.05 mmHg in the HFD group.
FIG. 5 is a graph showing the effect of Pat Control (FC) on the blood pressure of an experimental rat.
4. Visual Results
After the experiment, the results were as follows (Fig. 6). In visceral visceral fat, the amount of fat in the FC group was lower than that in the HFD group.
FIG. 6 is a photograph showing an open state after completion of the experiment. (Gross appearance of whole body and abdomen)
5. Long-term weighing results
5.1. Liver weight
The liver weight (Fig. 7) and the relative liver weight of the experimental animals obtained by oral administration of the fat control for 6 weeks in an animal model of high fat diet were converted into weight per 100 g in order to minimize the difference due to weight difference (Fig. 8).
In the liver weights, there was no significant difference, but the weight was decreased compared with the NC group. These results are the same as the results of the sample weight reduction by Lee (3) The results of this study are as follows.
FIG. 7 is a graph showing the effect of fat control according to weight comparison in liver of an experimental rat. (Effect of Fat Control on Liver Weight in ICR Mouse)
FIG. 8 is a graph showing the effect of the fat control according to the comparison of the relative weights of liver in the experimental mice. (Effect of Fat Control on Percent Liver Weight relative to Body Weight in ICR Mouse Obesity Model induced by a high fat diet)
5.2. Spleen weight
The spleen weight (Fig. 9) and the relative spleen weight of the experimental animals obtained by oral administration of the fat control for 6 weeks in a high fat diet animal model were expressed as 100 g body weight in order to minimize the difference due to the difference in body weight (Fig. 10).
Moon (6) et al. Showed that the difference in spleen weight between the normal group and the experimental group was maintained, but no significant difference was found in the spleen weight measurement in this experiment. In the FC group, .
FIG. 9 is a graph showing the effect of the Fat Control on the comparison of the weight of the spleen of an experimental rat. (Effect of Fat Control on Spleen Weight in ICR Mouse)
FIG. 10 is a graph showing the effect of fat control according to comparison of the relative weight of the spleen of an experimental mouse. (Effect of Fat Control on Percent Spleen weight relative to body weight in ICR mouse obesity model induced by a high fat diet)
5.3. Fat weight
The absolute long-term weights of retroperitoneal fat, epididymal fat, and peri-renal fat after the high fat diet and the test substance for 6 weeks are shown in Fig. 11, Fig. 13, Fig. 15 And the relative organ weights are shown in Fig. 12, Fig. 14, and Fig. 16. The fatty tissue weighed more than the HFD and SIM group in the FC group. This seems to affect body weight as well as weight loss.
FIG. 11 is a graph showing the effect of fat control according to weight comparison of peritoneal fat in experimental rats. (Effects of Fat Control on Retroperitoneal Fat Weight in a High Fat Diet)
FIG. 12 is a graph showing the effect of the fat control according to the comparison of the relative weights of the peritoneal fat of the experimental rats. (Effects of Fat Control on Retroperitoneal Fat Weight in ICR Mouse Obesity Model diet)
FIG. 13 is a graph showing the effect of fat control according to weight comparison of epididymal fat of an experimental rat. (Effects of Fat Control on Epididymal Fat Weight in a High Fat Diet)
FIG. 14 is a graph showing the effect of fat control on the comparison of the relative weight of epididymal fat of experimental rats. (Effects of Fat Control on Epididymal Fat Weight diet)
FIG. 15 is a graph showing the effect of fat control on the comparison of the weight of fat around the kidney of an experimental mouse. (Effect of Fat Control on peri-renal fat weight in a high fat diet )
FIG. 16 is a graph showing the effect of fat control on the comparison of the relative weight of the fat around the kidney of an experimental rat. (Effects of Fat Control on peri-renal fat weight relative to body weight in ICR mouse obesity model induced a high fat diet)
6. Histopathological test results
6.1. liver
The liver was stained with H & E staining. The results were as follows: Steatosis grade, lobular inflammation, hepatocellular ballooning, fat accumulation, inflammation, And the hepatocytes remained substantially spaced apart from the pronounced round nucleus. Similarly, most of the hepatic cells constituting the hepatic lobules except for the HFD group were uniformly arranged, and some hepatic cells were found to be deposited. In addition, fat accumulation and slight inflammation were observed in the control group HFD, and balloon shape was observed. In most of the experimental groups, many hepatocytes were uniformly arranged and the degree of fat accumulation was significantly reduced compared to the HFD group (Table 4, Fig. 17, Fig. 18). (P < 0.05).
Table 4. Effect of the Fat control on non-alcoholic steatohepatitis (NASH) scores in a ICR mice fed high fat diet for 6 weeks
[NC; Normal control group, HFD; High fat diet control group, SIM; HFD + Simvastatin 20 mg / kg, FC; HFD + Fat control , Values are Mean ± SD (p <0.05)]
FIG. 17 is a graph showing the effect of fat control according to fat accumulation results. (Results of non-alcoholic steatohepatitis (NASH) score calculation study to anti-obesity effects by Fat control)
Figure 18 is a photograph showing the effect of fat control according to fat accumulation results. (Effect of the Fat control on histological non-alcoholic steatohepatitis in a ICR mice fed high fat diet for 6 weeks. ))
6.2. Fat
The effects of chungkookjang on the fat cell size in high fat diet-induced obese mice were as follows (Table 5) (P <0.05). (Fig. 19, Fig. 20), retroperitoneal adipocytes (Fig. 21, Fig. 22) and adipocyte adipocytes (Fig. 23 and Fig. 24) There was a deviation according to the site. In the case of epididymal adipocytes and retroperitoneal adipocytes, there was a significant decrease in fat size when compared with the control group, HFD group , in the sample group, FC group . In particular, in the case of adipose adipose tissue, there was no significant difference in cell size between FC group, which is a sample administration group, and NC group, which is a normal group.
Table 5. Effect of the Fat control on histological adipocyte in a ICR mice obesity model induced by a high fat diet
(
μm
2
)
fat (
μm
2
)
(
μm
2
)
[NC; Normal control group, HFD; High fat diet control group, SIM; HFD + Simvastatin 20 mg / kg, FC; HFD + Fat control , Values are Mean ± SD (p <0.05)]
FIG. 19 is a graph showing the effect of Fat Control on the results of observation of epididymal fat cells. (Effect of the Fat Control on Epididymal Adipocyte Size in a ICR Mouse Obesity Model induced by a High Fat Diet)
Figure 20 is a photograph showing the effect of Fat Control on the results of observation of epididymal adipocytes. (Efficacy of the Fat control on Epididymal adipocyte size in a ICR mouse obesity model induced by a high fat diet. x400))
FIG. 21 is a graph showing the effect of Fat Control on the results of observation of peritoneal adipocytes. (Effect of the Fat Control on Retroperitoneal Adipocyte Size in a ICR Mouse Obesity Model Induced by a High Fat Diet.)
Figure 22 is a photograph showing the effect of the fat control according to the results of observation of the peritoneal adipocyte (H & E stain, H & E stain, and ICR mice obesity model induced by the retroperitoneal adipocyte size x400))
FIG. 23 is a graph showing the effect of fat control according to the results of observation of peripheral kidney fat cells. (Effect of the Fat Control on peri-renal adipocyte size in a ICR mouse obesity model induced by a high fat diet.)
Figure 24 is a photograph showing the effect of fat control according to the results of observation of the kidney peripheral adipocytes. (Effect of the Fat Control on peri-renal adipocyte size in ICR mouse obesity model induced by a high fat diet. stain, (x400))
Hereinafter, the efficacy and components of each material used will be briefly described on the basis of the results of research and experiments conducted by the inventor to help understand the present invention.
① Samcheon: The vegetable sulfur component contained in Samcheon has excellent ability to decompose cholesterol and triglyceride, purifies blood vessels cleanly, and has the effect of dissolving blood clots. In addition, the sulfur component prevents aging and cleanses the skin. In addition to sulfur, nitrogen, potassium, iron, manganese and zinc are the main constituents of the trilobium.
② Black garlic: Black garlic is abundant in sulfur compounds, and has a strong ability to remove active oxygen. It contains a lot of selenium, which is necessary for the activity of the antioxidant enzyme, peroxidase, to enhance the antioxidant power.
③ Hwanggi: The amino acid GABA contained in Hwanggi has blood pressure lowering effect, isoflavonoid has excellent antimicrobial action, and saponin has intestinal action. In particular, selenium in the hwanggi has antioxidant activity which prevents cell damage.
④ Ulgum: The main ingredients of Ulgum are curcumin and potassium. Potassium helps control blood pressure by effectively releasing sodium in the body. And curcumin has anti-cancer, anti-diabetic effect and improves vascular disease.
⑤ Gardenia: Gardenia's crotin and crocetin promote the secretion of bile and remove cholesterol to prevent blood clumping. It also relieves symptoms such as insomnia and palpitations caused by mental excitement due to sedation.
⑥ Sansa: In the pharmacological experiments, the alcohol extract shows sedative action and the flavonoid component shows the action of arteriosclerosis. In addition, capillary vasodilating action, coercive action, blood cholesterol reduction has been revealed. It also extends coronary vessels, which are also found in leaves, flowers, bark, stems, and roots. Sansa is a herb that greatly improves digestion function when roasted and ingested. The nature of Sansa is slightly warm and the taste is sweet. It is known as a drug that works on rain, stomach, and liver and improves the masturbation. Especially, they digest the meat well, stop the diarrhea, make the blood circulate well, release the eosinophilia, lower the blood pressure and reduce the blood cholesterol content.
⑦ rice bran: It is a by-product in the process of rice being cooked with rice husk and rice husk in the home made from brown rice to white rice. It is rich in nutrients of rice and contains various nutrients such as vitamin A, vitamin B1 and B6, iron and minerals have.
It is effective to prevent cancer through anticancer effect because it contains beta-cysterol and pitic acid. It is used as a pack to cover the skin and smooth the surface of the skin. It is good for skin beauty. It is rich in dietary fiber, It is good for relief and cleanse the chest.
SA100: Plant mixture preparation step
SA210: Hydrothermal extraction step of plant mixture
SA220: Plant mixture concentration step
SA230: Plant mixture powder step
SA300: Preparation step of rice bran
SA400: Product Completion Phase
Claims (2)
(b) mixing 5 to 7 liters of water with respect to 1 kg of the plant mixture of the above-prepared nine materials, followed by hot water extraction at 110 to 120 DEG C for 3 to 5 hours;
(c) heating the extracted plant mixture extract at a temperature of from 60 to 80 ° C for 5 to 7 hours to concentrate the concentrate to a concentration of 4 to 5 brix;
(d) The plant mixture of the nine materials prepared in the step (a) is steamed for 50 to 70 minutes with makgeolli, and the plant mixture is prepared by the method. Drying for 30 hours to form a powder;
(e) Mix the milk with the rice flour and mix it with hot water for 50 ~ 70 minutes. Add the lactic acid bacteria to the cooked rice flour at 35 ~ 45 ℃ and ferment it for 70 ~ 74 hours. Drying it for 20 to 30 hours and processing it into a fermented rice bran powder;
(c) is mixed at a ratio of 1: 0.2-0.4: 0.1-0.3, and the granulated product is processed into granules. The powder of step (d) ; ≪ / RTI >
In step (a), 10 to 20% by weight of yellowish green, 2 to 8% by weight of black garlic, 5 to 15% by weight of green tea, 5 to 15% by weight of malt, 5 to 15% To 20% by weight, from 10% by weight to 20% by weight and from 5% by weight to 15% by weight, of a natural mixture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150096723A KR101770468B1 (en) | 2015-07-07 | 2015-07-07 | Diet food manufacturing methods using natural mixture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150096723A KR101770468B1 (en) | 2015-07-07 | 2015-07-07 | Diet food manufacturing methods using natural mixture |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170006177A KR20170006177A (en) | 2017-01-17 |
KR101770468B1 true KR101770468B1 (en) | 2017-08-22 |
Family
ID=57990154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150096723A KR101770468B1 (en) | 2015-07-07 | 2015-07-07 | Diet food manufacturing methods using natural mixture |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101770468B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102065357B1 (en) * | 2018-07-31 | 2020-01-13 | 농업회사법인 주식회사 에이원이쌀눈 | Manufacturing method of rice bran fermented beverage composition |
KR102115622B1 (en) * | 2019-02-20 | 2020-05-27 | 박무순 | Pharmaceutical composition comprising the fermentation extract of medicinal or edible natural products as an effective component for prevention or treatment of thrombosis and health functional food comprising the same |
KR102337130B1 (en) * | 2021-07-20 | 2021-12-10 | 유동민 | Composition comprising fermented Oriental medicine herbs for preventing, improving or treating obesity, and method for preparing the same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0584045A (en) | 1991-09-27 | 1993-04-06 | Terumo Corp | Production of antiobese dried rice |
JPH05284937A (en) | 1992-04-10 | 1993-11-02 | T Ee C Gijutsu Kagaku Kenkyusho:Kk | Digestive enzyme activity-inhibiting substance extracted from sea alga and dietary food containing the same |
JPH06133731A (en) | 1992-10-23 | 1994-05-17 | Zenetsukusu Kk | Diet food |
JPH06343421A (en) | 1993-06-08 | 1994-12-20 | Yasutake Hichi | High fat food having antiobestic function |
-
2015
- 2015-07-07 KR KR1020150096723A patent/KR101770468B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20170006177A (en) | 2017-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101120787B (en) | Granada health-care beverage and its preparation method | |
CN102742837B (en) | Health food used for improving symptom of malnutrition and preparation method thereof | |
CN101381673A (en) | Haw vinegar healthy beverage and preparing process thereof | |
CN102919450B (en) | Cereal leaching solution herbal tea and method for preparing same | |
KR100852416B1 (en) | Cucurbitaceae vinegar composition | |
KR101883154B1 (en) | Method of manufacturing a fermented food that can help diabetes using the Hordeum vulgare L. and fermented food that has been produced by it | |
KR101770468B1 (en) | Diet food manufacturing methods using natural mixture | |
KR101621447B1 (en) | Pharmaceutical composition for anti-obesity comprising complex extracts including Saururi chinensis Baill. extract, Curcumae Longae Rhizoma extract and Polygalae Radix extract | |
CN107125426A (en) | A kind of sandwich Leechee ice cream of dragon fruit and preparation method thereof | |
CN107223846A (en) | A kind of suitable middle-aged and old grain healthcare powder | |
US20180296615A1 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
KR101122586B1 (en) | Hang over beverage containing freeze-dring Abalone flesh and It's manufacturing method | |
CN103695275B (en) | Method for preparing Korean-ginseng and sea cucumber wine | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
KR101350046B1 (en) | Vinegar composition fermented with herbal extracts and preparation method thereof | |
KR102498054B1 (en) | Manufacturing method of functional pizza dough using red rice and functional pizza dough produced by the method | |
KR102337130B1 (en) | Composition comprising fermented Oriental medicine herbs for preventing, improving or treating obesity, and method for preparing the same | |
KR20130130131A (en) | Vinegar composition fermented with black garlic and preparation method thereof | |
CN109744479A (en) | A kind of turkey weight-reducing jerky and preparation method thereof | |
CN104255883A (en) | Health protection cake capable of adjusting blood glucose and blood fat and production method thereof | |
KR100994071B1 (en) | The healthful foods | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
KR101344564B1 (en) | Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia | |
CN103045453A (en) | Purslane vinegar and production method thereof | |
Ye et al. | Traditional Chinese dates (Jujubes)-based functional foods in Chinese history |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |